83 related articles for article (PubMed ID: 20495968)
1. Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy.
Roth SL; Audretsch W; Bojar H; Lang I; Willers R; Budach W
Strahlenther Onkol; 2010 Jun; 186(6):299-306. PubMed ID: 20495968
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
Alvarado-Miranda A; Arrieta O; Gamboa-Vignolle C; Saavedra-Perez D; Morales-Barrera R; Bargallo-Rocha E; Zinser-Sierra J; Perez-Sanchez V; Ramirez-Ugalde T; Lara-Medina F
Radiat Oncol; 2009 Jul; 4():24. PubMed ID: 19591689
[TBL] [Abstract][Full Text] [Related]
3. Is FAST FORWARD the Way Forward in Radiotherapy for Locally Advanced Breast Cancer - Learnings From the COVID Pandemic.
Giridhar P; Pradhan S; Pujari L; Singh P; Shinghal A; Khandelwal C; Mukherjee C; Tripathi M; Shukla V; M V M; Choudary Z; Gupta A
Clin Breast Cancer; 2024 Apr; 24(3):e116-e125. PubMed ID: 38105131
[TBL] [Abstract][Full Text] [Related]
4. Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
Diessner J; Wischnewsky M; Blettner M; Häusler S; Janni W; Kreienberg R; Stein R; Stüber T; Schwentner L; Bartmann C; Wöckel A
PLoS One; 2016; 11(12):e0168730. PubMed ID: 27992550
[TBL] [Abstract][Full Text] [Related]
5. Optimising adjuvant breast radiotherapy via preoperative imaging.
Braunstein LZ
Lancet; 2024 Jan; 403(10423):222-224. PubMed ID: 38065195
[No Abstract] [Full Text] [Related]
6. Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.
Ribeiro J; Sousa B; Cardoso F
EJC Suppl; 2013 Sep; 11(2):3-22. PubMed ID: 26217109
[No Abstract] [Full Text] [Related]
7. Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstruction.
Yuan J; Zhang M; Wang M; Zhang M; Wu K; Chen H
Sci Rep; 2024 Apr; 14(1):9208. PubMed ID: 38649431
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Haussmann J; Budach W; Nestle-Krämling C; Wollandt S; Tamaskovics B; Corradini S; Bölke E; Krug D; Fehm T; Ruckhäberle E; Audretsch W; Jazmati D; Matuschek C
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011025
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant radiotherapy in triple-negative breast cancer: "the past should not steal the present or hide the future".
To NH; Radosevic-Robin N; Belkacemi Y
Rep Pract Oncol Radiother; 2022; 27(1):180-181. PubMed ID: 35402032
[No Abstract] [Full Text] [Related]
10. A systematic review of neo-adjuvant radiotherapy in the treatment of breast cancer.
Ahmed M; Jozsa F; Douek M
Ecancermedicalscience; 2021; 15():1175. PubMed ID: 33680089
[TBL] [Abstract][Full Text] [Related]
11. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.
de Mey S; Dufait I; Jiang H; Corbet C; Wang H; Van De Gucht M; Kerkhove L; Law KL; Vandenplas H; Gevaert T; Feron O; De Ridder M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33316932
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.
Van Hulle H; Vakaet V; Post G; Van Greveling A; Monten C; Hendrix A; Van de Vijver K; Van Dorpe J; De Visschere P; Braems G; Vandecasteele K; Denys H; De Neve W; Veldeman L
Pilot Feasibility Stud; 2020; 6():154. PubMed ID: 33062295
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited.
Matuschek C; Nestle-Kraemling C; Kühn T; Fehm T; Bölke E; Corradini S; Fastner G; Maas K; Seidel C; Budach W
Breast Care (Basel); 2020 Apr; 15(2):112-117. PubMed ID: 32398979
[TBL] [Abstract][Full Text] [Related]
14. Long-term quality of life after preoperative radiochemotherapy in patients with localized and locally advanced breast cancer.
Haussmann J; Nestle-Kraemling C; Bölke E; Wollandt S; Speer V; Djiepmo Njanang FJ; Tamaskovics B; Gerber PA; Orth K; Ruckhaeberle E; Fehm T; Corradini S; Lammering G; Mohrmann S; Audretsch W; Maas K; Roth S; Kammers K; Budach W; Matuschek C
Strahlenther Onkol; 2020 Apr; 196(4):386-397. PubMed ID: 31919547
[TBL] [Abstract][Full Text] [Related]
15. Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients.
Matuschek C; Nestle-Kraemling C; Haussmann J; Bölke E; Wollandt S; Speer V; Djiepmo Njanang FJ; Tamaskovics B; Gerber PA; Orth K; Ruckhaeberle E; Fehm T; Corradini S; Lammering G; Mohrmann S; Audretsch W; Roth S; Kammers K; Budach W
Strahlenther Onkol; 2019 Jul; 195(7):615-628. PubMed ID: 31101954
[TBL] [Abstract][Full Text] [Related]
16. Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery.
López Alfonso JC; Poleszczuk J; Walker R; Kim S; Pilon-Thomas S; Conejo-Garcia JJ; Soliman H; Czerniecki B; Harrison LB; Enderling H
JCO Clin Cancer Inform; 2019 Apr; 3():1-16. PubMed ID: 30964698
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer.
O' Halloran N; McVeigh T; Martin J; Keane M; Lowery A; Kerin M
Ir J Med Sci; 2019 Feb; 188(1):75-83. PubMed ID: 29948462
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Radiotherapy Is Not Associated with Increased Post-mastectomy Short-term Morbidity: Analysis of 77,902 Patients.
Baltodano PA; Reinhardt ME; Flores JM; Abreu FM; Chattha A; Kone L; Cooney CM; Manahan MA; Zellars RC; Rosson GD
Plast Reconstr Surg Glob Open; 2017 Mar; 5(3):e1108. PubMed ID: 28458959
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction : An alternative treatment option for locally advanced breast cancer.
Pazos M; Corradini S; Dian D; von Bodungen V; Ditsch N; Wuerstlein R; Schönecker S; Harbeck N; Scheithauer H; Belka C
Strahlenther Onkol; 2017 Apr; 193(4):324-331. PubMed ID: 28124093
[TBL] [Abstract][Full Text] [Related]
20. The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation.
Kötter B; Frey B; Winderl M; Rubner Y; Scheithauer H; Sieber R; Fietkau R; Gaipl US
Radiat Oncol; 2015 Sep; 10():197. PubMed ID: 26383236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
